PL420629A1 - New derivatives of carbamates and their application - Google Patents

New derivatives of carbamates and their application

Info

Publication number
PL420629A1
PL420629A1 PL420629A PL42062917A PL420629A1 PL 420629 A1 PL420629 A1 PL 420629A1 PL 420629 A PL420629 A PL 420629A PL 42062917 A PL42062917 A PL 42062917A PL 420629 A1 PL420629 A1 PL 420629A1
Authority
PL
Poland
Prior art keywords
application
carbamates
new derivatives
subject
new
Prior art date
Application number
PL420629A
Other languages
Polish (pl)
Other versions
PL232831B1 (en
Inventor
Dariusz Kozakiewicz
Jarosław Polański
Josef Jampilek
Ales Imramowsky
Sarka Stepankova
Original Assignee
Uniwersytet Śląski W Katowicach
Dk Chem Organic Synthesis Ltd Spółka Komandytowa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Śląski W Katowicach, Dk Chem Organic Synthesis Ltd Spółka Komandytowa filed Critical Uniwersytet Śląski W Katowicach
Priority to PL420629A priority Critical patent/PL232831B1/en
Publication of PL420629A1 publication Critical patent/PL420629A1/en
Publication of PL232831B1 publication Critical patent/PL232831B1/en

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Przedmiotem zgłoszenia jest nowa pochodna karbaminianów, która charakteryzuje się tym, że ma strukturę chemiczną według wzoru 1, gdzie R1 stanowi grupę metylową, R2 - grupę metylową, R3 - grupę metylową, fenylową lub benzylową. Przedmiotem zgłoszenia jest też zastosowanie nowych pochodnych karbaminianów do wytwarzania substancji czynnych przeznaczonych do leczenia choroby Alzheimera.The subject of the application is a new derivative of carbamates, which is characterized in that it has a chemical structure according to formula 1, where R1 is a methyl group, R2 is a methyl group, R3 is a methyl, phenyl or benzyl group. The subject of the application is also the use of new carbamate derivatives for the production of active substances intended for the treatment of Alzheimer's disease.

PL420629A 2017-02-23 2017-02-23 New derivatives of carbamates and their application PL232831B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL420629A PL232831B1 (en) 2017-02-23 2017-02-23 New derivatives of carbamates and their application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL420629A PL232831B1 (en) 2017-02-23 2017-02-23 New derivatives of carbamates and their application

Publications (2)

Publication Number Publication Date
PL420629A1 true PL420629A1 (en) 2018-08-27
PL232831B1 PL232831B1 (en) 2019-07-31

Family

ID=63229342

Family Applications (1)

Application Number Title Priority Date Filing Date
PL420629A PL232831B1 (en) 2017-02-23 2017-02-23 New derivatives of carbamates and their application

Country Status (1)

Country Link
PL (1) PL232831B1 (en)

Also Published As

Publication number Publication date
PL232831B1 (en) 2019-07-31

Similar Documents

Publication Publication Date Title
PH12020500265A1 (en) Indole carboxamides compounds useful as kinase inhibitors
NI201900041A (en) 1, 2, 4-TRIAZOLONES 2, 4, 5-TRISUSTITUIDAS
NZ730794A (en) Modulators of cystic fibrosis transmembrane conductance regulator
ECSP18083519A (en) BROMODOMINES INHIBITORS
PH12016501813A1 (en) 1,3-benzodioxole derivative
MX2015008957A (en) Fluoro-[1,3]oxazines as bace1 inhibitors.
CL2015000578A1 (en) Compound n- (2- (6-fluoro-1-h-indol-3-yl) ethyl) -3- (2,2,3,3-tetrafluoropropoxy) benzylamine or its salt, 5-ht6 receptor antagonist; pharmaceutical composition; Use in the treatment of Alzheimer's disease.
MX2017006447A (en) Antifungal agents.
AR100818A1 (en) N- (CYANOMETIL) -4- (2- (4-MORFOLINOFENILAMINO) PIRIMIDIN-4-IL) BENZAMIDA
GEP20196949B (en) 2-amino-6-(difluoromethyl)-5, 5-difluoro-6-phenyl-3, 4, 5, 6-tetra- hydropyridines as bace1 inhibitors
BR112017004673A2 (en) 2- (4- (4-Ethoxy-6-oxo-1,6-dihydropyridin-3-yl) -2-fluorophenyl) -n- (5- (1,1,1-trifluoro-2-methylpropan) crystalline forms -2-yl) isoxazol-3-yl) acetamide
PH12015502365B1 (en) Bace1 inhibitors
EA201790627A1 (en) STEMULATORS RHC
EA201990400A1 (en) COMPOUNDS AND COMPOSITIONS AND THEIR APPLICATION
CL2018003431A1 (en) Treatment of parkinson's disease.
MX2019011774A (en) Substituted n-(-1,3,4-oxadiazole-2-yl)aryl carboxamides and the use thereof as herbicides.
CO7131369A2 (en) 5-amino [1,4] thiazines as bace1 inhibitors
CO7151509A2 (en) Difluoro-hexahydro-cyclopentaoxacinyls and difluoro-hexahydro-benzooxacinyls as bace1 inhibitors
PL420626A1 (en) New derivatives of carbamates and their application
PH12017501668A1 (en) Bace1 inhibitors
EA201990766A1 (en) INDOSOLIC COMPOUNDS FOR USE IN DAMAGE OF THE TENDON AND / OR Ligaments
MX2019002104A (en) 3-pyridyloxyphenyldihydrouracil compound and use thereof.
BR112018074162A2 (en) pharmaceutical compositions suitable for oral administration and parenteral administration, methods for preventing or treating fungal infection in a human or animal individual and for producing a pharmaceutical composition, and use of a pharmaceutical composition.
TR201910158T4 (en) Preventive and / or therapeutic agent for immune diseases.
PL420629A1 (en) New derivatives of carbamates and their application